A Study of Dual-SIgnaling Protein 107 (DSP107) for Patients With Hematological Malignancies

Clinical trial NCT04937166 · TERMINATED

Trial details

NCT number: NCT04937166
Sponsor: Kahr Medical
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia

Start date: 2022-01-13
Primary completion: 2025-04-23
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.